Stay updated with breaking news from Technology Development Board. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The first nasal vaccine manufactured in India, called "iNCOVACC," will be introduced on Thursday by Union Health Minister Dr. Mansukh Mandaviya.
Bharat Biotech's iNCOVACC will be the country of India's first needleless booster shot which will be available in private hospitals.
Bharat Biotech has introduced iNCOVACC (BBV154) as a booster dosage in the nation.
Bharat Biotech on Tuesday announced that its intranasal covid heterologous booster iNCOVACC️ (BBV154) is scheduled to be introduced in the country in the fourth week of January and will cost Rs 800 privately and Rs 325 for large central and state government procurements.
The intranasal vaccine, iNCOVACC (BBV154), is now available on CoWin, and priced at Rs 800 for private markets and Rs 325 for supplies to the Centre and state governments,